Bringing you the worlds first patient-friendly catheter
Here at UroSense, we re-innovate the current Foley catheter.
The aim is to reduce CAUTI rates, decreasing antibiotic cost.
We are on a mission to
disrupt the urological space
Here at UroSense, we re-innovate the current Foley catheter. The aim is to reduce CAUTI rates, decreasing antibiotic costs
The aim is to improve the striking UK catheter-associate unrinary infection (CAUTI) rates, with the ultimate goal being to also see improvements in global CAUTI rates.
A Problem Long Overdue
We have an issue, a life-threatening issue, a life-threatening issue. Right now, the medical field is succumbing to the detrimental yet preventable effects of catheter-associated urinary tract infectious (CAUTIs) The most common healthcare associate infection worldwide. Current catheters were design nearly 80 years ago, and haven't faced any significant change since then
The most common healthcare associated infection worldwide
In the UK, a £100M economical burden is inflicted on the NHS annually. Urinary catheters account for 2000 preventable deaths every year.
15 - 25% of catheterized hospital patients receive a catheter
5% increased risk of infection each day
£1900 spent per CAUTI episode
50% of catheterized patients in care home develop asymptomatic UTIs.
Catheter blockage occurs.
Continual antibiotic use results in bacterial resistance.
> 28 Days
< 28 Days
Santander and Future worlds
UCL Explore prize
Most accelerated startup